{"schema_version":"secwatch.filing_event.v1","accession":"0001872789-25-000016","form_type":"8-K","ticker":"EMBC","cik":"0001872789","company_name":"Embecta Corp.","filed_at":"2025-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.319469+00:00","generated_at":"2026-05-20T18:53:54.591701+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Embecta reaffirms FY2025 guidance, unveils long-range plan with flat revenue growth, $600M FCF target","bullets":["Reaffirmed FY2025 guidance: revenue $1.073-1.090B, adjusted EPS $2.70-$2.90, adjusted gross margin 62.75%-63.75%.","Long-range plan (2025-2028): flattish constant currency revenue CAGR, adjusted operating margin ~28%-30%.","Targets ~$600M cumulative free cash flow over LRP; plans to repay $450M-$500M of debt.","Strategic priorities: strengthen core insulin injection business, expand product portfolio, increase financial flexibility through cost savings and debt reduction.","Inaugural Analyst and Investor Day held May 22, 2025, with webcast and presentation materials available online."],"urls":{"canonical":"https://secwatch.observer/filing/0001872789-25-000016","json":"https://secwatch.observer/filing/0001872789-25-000016.json","markdown":"https://secwatch.observer/filing/0001872789-25-000016.md","text":"https://secwatch.observer/filing/0001872789-25-000016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1872789/000187278925000016/0001872789-25-000016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1872789/000187278925000016/embc-20250522.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T18:53:54.591701+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}